{"id":"W2305775710","doi":"10.1161/circoutcomes.6.suppl_1.a200","title":"Abstract 200: Cost-Effectiveness of Newer Anticoagulants for Stroke Prevention in Atrial Fibrillation","year":2013,"lang":"en","type":"article","venue":"Circulation Cardiovascular Quality and Outcomes","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Dabigatran; Rivaroxaban; Apixaban; Medicine; Atrial fibrillation; Stroke (engine); Warfarin; Randomized controlled trial; Quality-adjusted life year; Cost effectiveness; Internal medicine; Risk analysis (engineering)","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007703426,0.001068451,0.003792827,0.005305945,0.0002210898,0.002638538,0.001001504,0.001449956,0.007129431],"category_scores_gemma":[0.03810178,0.0005505489,0.008193756,0.005280385,0.0004325698,0.001780363,0.0005757536,0.001020961,0.0003529221],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003900895,"about_ca_system_score_gemma":0.004848503,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.006125306,"about_ca_topic_score_gemma":0.007613677,"domain_scores_codex":[0.9919968,0.005090015,0.001534521,0.0003212561,0.0009484426,0.000109056],"domain_scores_gemma":[0.965601,0.02879255,0.003976982,0.0003513051,0.001103944,0.0001741614],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.004092219,0.0004274338,0.0206011,0.647793,0.1180089,0.0006882169,0.000196076,0.04868368,0.0006035526,0.009148884,0.02177355,0.1279834],"study_design_scores_gemma":[0.01285212,0.005493771,0.05996992,0.4510572,0.2808054,0.003318239,0.0005541691,0.07709082,0.001524707,0.04181314,0.06515002,0.0003705674],"study_design_candidate":"meta_analysis","study_design_consensus":null,"genre_codex":"review","genre_gemma":"empirical","genre_scores_codex":[0.03848063,0.9339989,0.004239907,0.004410194,0.0006906958,0.001435366,0.009969749,0.00009465507,0.006679831],"genre_scores_gemma":[0.4847371,0.4983052,0.007247815,0.001688727,0.000778179,0.002000512,0.004196628,0.00004410552,0.001001609],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.007703426,"threshold_uncertainty_score":0.04074007,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1477288973033117,"score_gpt":0.3960044855694982,"score_spread":0.2482755882661865,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}